The hour was marked by significant advancements in biotechnology and strategic shifts in artificial intelligence. Moderna and Merck announced that their personalized mRNA cancer vaccine, intismeran, successfully prevented melanoma recurrence in phase 3 clinical trials, sparking a market rally in related biotech stocks that sent Iovance Biotherapeutics to a 52-week high. Meanwhile, the technology sector saw major consolidation and policy adjustments; Stripe moved to acquire AI infrastructure platform OpenRouter for $7 billion, and OpenAI dramatically curtailed the use of Reddit citations in ChatGPT in favor of trusted, official sources. Corporate performance reports highlighted a fragmented economic landscape: while companies like Webull posted record profits driven by trading volume, Wolfspeed shares fell 11% following an earnings miss that underscores the volatility facing AI-adjacent hardware manufacturers. The luxury sector showed resilience, as Toll Brothers maintained its full-year outlook despite rising prices, bolstered by a cohort of buyers where 25% pay entirely in cash. In international news, a helicopter crash in Kenya claimed the lives of seven individuals, including five U.S. citizens. Legal and government activity included the indictment of a former West Virginia sheriff’s deputy for the deprivation of rights regarding a female inmate, and the sentencing of a member of the extremist 764 group to 77 years in prison for the production and distribution of illicit materials.